AMAG is a pharmaceutical company focused on bringing innovative products to patients with unmet medical needs. This company truly puts patients and their families at the center of everything they do. Whether developing and marketing innovative treatments, driving condition awareness, or creating educational tools, AMAG always asks the question “How can we help even more people living with this medical condition?”
- AMAG is especially innovative in how it breaks down barriers to better care. Intrarosa is a therapy for moderate to severe dyspareunia (painful sex due to menopause), a condition not well known due to the emotional sadness and loss of intimacy that is exacerbated by a stigma preventing women from discussing their experiences. The AMAG Digital Engagement Team created a first-of-its-kind chatbot that provides women suffering with dyspareunia a supportive resource in a way that is discoverable, intuitive, and informative.
- AMAG is also investing in women’s health to develop a potential treatment for severe preeclampsia, a serious pregnancy complication that threatens the lives of mothers and babies. Preeclampsia is a contributing factor in a significant number of preterm births in the U.S., yet no approved treatment options currently exists.
- AMAG’s culture thrives on energy, focus, and an entrepreneurial spirit. AMAG employees hold themselves accountable to the company’s values and work together to cultivate a sense of understanding, awareness, and empathy for the patients and families they support.
- AMAG is committed to fostering a diverse workplace. With a variety of backgrounds and experiences, the team works together to create an environment that empowers employees to lead, learn, and grow.
- AMAG employees are encouraged by the company to take on volunteer endeavors, especially those that improve the health and well-being of mothers and babies.
- AMAG partners with leading maternal and minority health experts to identify and address barriers to better health for mothers and babies in the U.S. Convened by AMAG in 2016, the Maternal and Infant Health Inequities Working Group brought together leaders in maternal and infant health to help reduce health inequities and improve the health of mothers and babies in communities across the nation. The Working Group conducted research to help clinicians communicate more effectively with African-American women about risks for preterm birth and steps they can take.
- With a shared commitment to helping mothers and babies thrive, the company formed a strategic partnership with March of Dimes that aims to improve maternal health and birth outcomes as well as reduce health inequities.